image
Healthcare - Medical - Healthcare Information Services - NYSE - US
$ 18.04
-14.1 %
$ 1.04 B
Market Cap
-10.8
P/E
1. INTRINSIC VALUE

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients.[ Read More ]

The intrinsic value of one PHR stock under the base case scenario is HIDDEN Compared to the current market price of 18 USD, Phreesia, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart PHR

image
FINANCIALS
356 M REVENUE
26.84%
-132 M OPERATING INCOME
25.36%
-137 M NET INCOME
22.29%
-32.4 M OPERATING CASH FLOW
64.07%
-39.7 M INVESTING CASH FLOW
-51.39%
-17.1 M FINANCING CASH FLOW
16.13%
102 M REVENUE
0.89%
-17.2 M OPERATING INCOME
11.32%
-18 M NET INCOME
8.67%
11.1 M OPERATING CASH FLOW
1367.01%
-7.4 M INVESTING CASH FLOW
-35.93%
-1.38 M FINANCING CASH FLOW
17.45%
Balance Sheet Decomposition Phreesia, Inc.
image
Current Assets 196 M
Cash & Short-Term Investments 87.5 M
Receivables 64.9 M
Other Current Assets 43.3 M
Non-Current Assets 175 M
Long-Term Investments 0
PP&E 17.2 M
Other Non-Current Assets 157 M
Current Liabilities 110 M
Accounts Payable 8.48 M
Short-Term Debt 6.45 M
Other Current Liabilities 95.2 M
Non-Current Liabilities 8.76 M
Long-Term Debt 5.53 M
Other Non-Current Liabilities 3.22 M
EFFICIENCY
Earnings Waterfall Phreesia, Inc.
image
Revenue 356 M
Cost Of Revenue 155 M
Gross Profit 202 M
Operating Expenses 335 M
Operating Income -132 M
Other Expenses 5.11 M
Net Income -137 M
RATIOS
56.62% GROSS MARGIN
56.62%
-36.98% OPERATING MARGIN
-36.98%
-38.42% NET MARGIN
-38.42%
-54.44% ROE
-54.44%
-36.96% ROA
-36.96%
-52.35% ROIC
-52.35%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Phreesia, Inc.
image
Net Income -137 M
Depreciation & Amortization 29.5 M
Capital Expenditures -25.1 M
Stock-Based Compensation 71.6 M
Change in Working Capital -1.64 M
Others 16.4 M
Free Cash Flow -57.5 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Phreesia, Inc.
image
Wall Street analysts predict an average 1-year price target for PHR of $30.7 , with forecasts ranging from a low of $23 to a high of $35 .
PHR Lowest Price Target Wall Street Target
23 USD 27.49%
PHR Average Price Target Wall Street Target
30.7 USD 70.18%
PHR Highest Price Target Wall Street Target
35 USD 94.01%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Phreesia, Inc.
image
Sold
0-3 MONTHS
1.16 M USD 8
3-6 MONTHS
379 K USD 9
6-9 MONTHS
2.25 M USD 7
9-12 MONTHS
4.7 M USD 8
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
4 weeks ago
Oct 18, 2024
Sell 22.5 K USD
Linetsky David
SVP, Life Sciences
- 1100
20.49 USD
1 month ago
Oct 15, 2024
Sell 18.2 K USD
Gandhi Balaji
Chief Financial Officer
- 864
21.0251 USD
1 month ago
Oct 15, 2024
Sell 25.5 K USD
Hoffman Allison C
General Counsel & Secretary
- 1212
21.0251 USD
1 month ago
Oct 15, 2024
Sell 64.9 K USD
Indig Chaim
Chief Executive Officer
- 3089
21.0251 USD
1 month ago
Oct 15, 2024
Sell 42.3 K USD
Linetsky David
SVP, Life Sciences
- 2011
21.0251 USD
1 month ago
Oct 15, 2024
Sell 38.7 K USD
Roberts Evan
Chief Operating Officer
- 1843
21.0251 USD
1 month ago
Oct 15, 2024
Sell 13.1 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 624
21.0251 USD
1 month ago
Oct 15, 2024
Sell 52 K USD
Hui Yvonne
Principal Accounting Officer
- 2485
20.91 USD
1 month ago
Oct 15, 2024
Sell 6.43 K USD
Hui Yvonne
Principal Accounting Officer
- 306
21.0251 USD
1 month ago
Oct 16, 2024
Sell 9.02 K USD
Hui Yvonne
Principal Accounting Officer
- 423
21.33 USD
1 month ago
Sep 19, 2024
Sell 577 USD
Linetsky David
SVP, Life Sciences
- 24
24.0433 USD
2 months ago
Sep 17, 2024
Sell 892 USD
Linetsky David
SVP, Life Sciences
- 36
24.7651 USD
1 month ago
Sep 18, 2024
Sell 1.47 K USD
Linetsky David
SVP, Life Sciences
- 61
24.0866 USD
2 months ago
Sep 12, 2024
Sell 32.2 K USD
Egbuonu-Davis Lisa
Director
- 1400
23.028 USD
2 months ago
Sep 10, 2024
Sell 81.4 K USD
Gandhi Balaji
Chief Financial Officer
- 3502
23.2502 USD
2 months ago
Sep 10, 2024
Sell 17.3 K USD
Hui Yvonne
Principal Accounting Officer
- 744
23.2502 USD
2 months ago
Sep 10, 2024
Sell 123 K USD
Indig Chaim
Chief Executive Officer
- 5295
23.2502 USD
2 months ago
Sep 10, 2024
Sell 39.9 K USD
Linetsky David
SVP, Life Sciences
- 1716
23.2502 USD
2 months ago
Sep 10, 2024
Sell 2.21 K USD
Linetsky David
SVP, Life Sciences
- 95
23.2502 USD
2 months ago
Sep 10, 2024
Sell 73.2 K USD
Roberts Evan
Chief Operating Officer
- 3148
23.2502 USD
2 months ago
Sep 10, 2024
Sell 17.1 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 737
23.2502 USD
2 months ago
Sep 10, 2024
Sell 61 K USD
Hoffman Allison C
General Counsel & Secretary
- 2622
23.2502 USD
2 months ago
Sep 11, 2024
Sell 48.4 K USD
Hoffman Allison C
General Counsel & Secretary
- 2072
23.36 USD
2 months ago
Aug 26, 2024
Sell 367 K USD
Hoffman Allison C
General Counsel & Secretary
- 14110
26.027 USD
3 months ago
Jul 29, 2024
Sell 173 USD
Indig Chaim
Chief Executive Officer
- 7
24.75 USD
4 months ago
Jul 18, 2024
Sell 175 K USD
Smith Mark Douglas
Director
- 7000
25 USD
4 months ago
Jul 16, 2024
Sell 43.2 K USD
Linetsky David
SVP, Life Sciences
- 1820
23.7356 USD
4 months ago
Jul 16, 2024
Sell 62.8 K USD
Indig Chaim
Chief Executive Officer
- 2644
23.7356 USD
4 months ago
Jul 16, 2024
Sell 6.72 K USD
Hui Yvonne
Principal Accounting Officer
- 283
23.7356 USD
4 months ago
Jul 16, 2024
Sell 19 K USD
Hoffman Allison C
General Counsel & Secretary
- 800
23.7356 USD
4 months ago
Jul 16, 2024
Sell 18.6 K USD
Gandhi Balaji
Chief Financial Officer
- 783
23.7356 USD
4 months ago
Jul 16, 2024
Sell 8.88 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 374
23.7356 USD
4 months ago
Jul 16, 2024
Sell 39.6 K USD
Roberts Evan
Chief Operating Officer
- 1669
23.7356 USD
4 months ago
Jun 21, 2024
Sell 2.31 K USD
Gunzburg Janet
Principal Accounting Officer
- 114
20.2365 USD
4 months ago
Jun 21, 2024
Sell 546 USD
Linetsky David
SVP, Life Sciences
- 27
20.2365 USD
5 months ago
Jun 18, 2024
Sell 787 USD
Linetsky David
SVP, Life Sciences
- 41
19.1971 USD
4 months ago
Jun 20, 2024
Sell 1.3 K USD
Linetsky David
SVP, Life Sciences
- 66
19.7322 USD
6 months ago
May 01, 2024
Sell 6.01 K USD
Gunzburg Janet
Principal Accounting Officer
- 286
20.9987 USD
7 months ago
Apr 18, 2024
Sell 20.8 K USD
Gunzburg Janet
Principal Accounting Officer
- 912
22.847 USD
7 months ago
Apr 18, 2024
Sell 6.15 K USD
Linetsky David
SVP, Life Sciences
- 269
22.847 USD
7 months ago
Apr 15, 2024
Sell 15.7 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 685
22.8574 USD
7 months ago
Apr 15, 2024
Sell 50.6 K USD
Linetsky David
SVP, Life Sciences
- 2212
22.8574 USD
7 months ago
Apr 15, 2024
Sell 46.4 K USD
Roberts Evan
Chief Operating Officer
- 2029
22.8574 USD
7 months ago
Apr 15, 2024
Sell 28.3 K USD
Hoffman Allison C
General Counsel & Secretary
- 1238
22.8574 USD
7 months ago
Apr 15, 2024
Sell 21.7 K USD
Gandhi Balaji
Chief Financial Officer
- 948
22.8574 USD
7 months ago
Apr 15, 2024
Sell 77.5 K USD
Indig Chaim
Chief Executive Officer
- 3392
22.8574 USD
7 months ago
Apr 10, 2024
Sell 63.9 K USD
Gunzburg Janet
Principal Accounting Officer
- 2768
23.0954 USD
7 months ago
Apr 08, 2024
Sell 124 K USD
Hoffman Allison C
General Counsel & Secretary
- 5494
22.6161 USD
7 months ago
Apr 08, 2024
Sell 1.27 K USD
Hoffman Allison C
General Counsel & Secretary
- 55
23.0163 USD
7 months ago
Apr 09, 2024
Sell 108 K USD
Hoffman Allison C
General Counsel & Secretary
- 4626
23.4241 USD
7 months ago
Apr 08, 2024
Sell 174 K USD
Gandhi Balaji
Chief Financial Officer
- 7700
22.6161 USD
7 months ago
Apr 08, 2024
Sell 1.8 K USD
Gandhi Balaji
Chief Financial Officer
- 78
23.0163 USD
7 months ago
Apr 08, 2024
Sell 270 K USD
Indig Chaim
Chief Executive Officer
- 11923
22.6161 USD
7 months ago
Apr 08, 2024
Sell 2.76 K USD
Indig Chaim
Chief Executive Officer
- 120
23.0163 USD
7 months ago
Apr 08, 2024
Sell 75.1 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 3320
22.6161 USD
7 months ago
Apr 08, 2024
Sell 783 USD
VanDuyn Amy Beth
SVP, Human Resources
- 34
23.0163 USD
7 months ago
Apr 09, 2024
Sell 88.3 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 3768
23.428 USD
7 months ago
Apr 08, 2024
Sell 161 K USD
Roberts Evan
Chief Operating Officer
- 7106
22.6161 USD
7 months ago
Apr 08, 2024
Sell 1.66 K USD
Roberts Evan
Chief Operating Officer
- 72
23.0163 USD
7 months ago
Apr 08, 2024
Sell 87.6 K USD
Linetsky David
SVP, Life Sciences
- 3875
22.6161 USD
7 months ago
Apr 08, 2024
Sell 898 USD
Linetsky David
SVP, Life Sciences
- 39
23.0163 USD
7 months ago
Apr 08, 2024
Sell 5.54 K USD
Linetsky David
SVP, Life Sciences
- 245
22.6161 USD
7 months ago
Apr 08, 2024
Sell 46 USD
Linetsky David
SVP, Life Sciences
- 2
23.0163 USD
7 months ago
Mar 19, 2024
Sell 65.6 K USD
Gunzburg Janet
Principal Accounting Officer
- 2817
23.2733 USD
7 months ago
Apr 08, 2024
Sell 38.3 K USD
Gunzburg Janet
Principal Accounting Officer
- 1692
22.6161 USD
7 months ago
Apr 08, 2024
Sell 391 USD
Gunzburg Janet
Principal Accounting Officer
- 17
23.0163 USD
7 months ago
Mar 25, 2024
Sell 81.3 K USD
Gandhi Balaji
Chief Financial Officer
- 3504
23.2112 USD
7 months ago
Mar 21, 2024
Sell 586 K USD
Roberts Evan
Chief Operating Officer
- 24962
23.4848 USD
7 months ago
Mar 21, 2024
Sell 24.5 K USD
Roberts Evan
Chief Operating Officer
- 1000
24.4568 USD
7 months ago
Mar 20, 2024
Sell 3.24 K USD
Gunzburg Janet
Principal Accounting Officer
- 137
23.6597 USD
7 months ago
Mar 20, 2024
Sell 710 USD
Linetsky David
SVP, Life Sciences
- 30
23.6597 USD
8 months ago
Mar 18, 2024
Sell 1.02 K USD
Linetsky David
SVP, Life Sciences
- 46
22.2162 USD
7 months ago
Mar 19, 2024
Sell 9.36 K USD
Linetsky David
SVP, Life Sciences
- 402
23.2733 USD
9 months ago
Feb 09, 2024
Sell 13.4 K USD
Gunzburg Janet
Principal Accounting Officer
- 480
28 USD
9 months ago
Feb 02, 2024
Sell 13 K USD
Gunzburg Janet
Principal Accounting Officer
- 480
27 USD
10 months ago
Jan 12, 2024
Sell 4.94 K USD
Gunzburg Janet
Principal Accounting Officer
- 205
24.11 USD
9 months ago
Feb 01, 2024
Sell 8.52 K USD
Gunzburg Janet
Principal Accounting Officer
- 328
25.9898 USD
10 months ago
Jan 16, 2024
Sell 22.9 K USD
Gandhi Balaji
Chief Financial Officer
- 932
24.5455 USD
10 months ago
Jan 17, 2024
Sell 222 K USD
Gandhi Balaji
Chief Financial Officer
- 9192
24.1216 USD
10 months ago
Jan 16, 2024
Sell 18.1 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 738
24.5455 USD
10 months ago
Jan 17, 2024
Sell 246 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 10213
24.1216 USD
10 months ago
Jan 16, 2024
Sell 32.2 K USD
Davidoff Michael J.
SVP, Payer Business
- 1310
24.5455 USD
10 months ago
Jan 17, 2024
Sell 426 K USD
Davidoff Michael J.
SVP, Payer Business
- 17677
24.1216 USD
10 months ago
Jan 16, 2024
Sell 56.9 K USD
Linetsky David
SVP, Life Sciences
- 2318
24.5455 USD
10 months ago
Jan 17, 2024
Sell 740 K USD
Linetsky David
SVP, Life Sciences
- 30659
24.1216 USD
10 months ago
Jan 16, 2024
Sell 32.3 K USD
Hoffman Allison C
General Counsel & Secretary
- 1316
24.5455 USD
10 months ago
Jan 17, 2024
Sell 183 K USD
Hoffman Allison C
General Counsel & Secretary
- 7605
24.1216 USD
10 months ago
Jan 16, 2024
Sell 55.2 K USD
Roberts Evan
Chief Operating Officer
- 2247
24.5455 USD
10 months ago
Jan 17, 2024
Sell 991 K USD
Roberts Evan
Chief Operating Officer
- 41081
24.1216 USD
10 months ago
Jan 16, 2024
Sell 88 K USD
Indig Chaim
Chief Executive Officer
- 3586
24.5455 USD
10 months ago
Jan 17, 2024
Sell 1.54 M USD
Indig Chaim
Chief Executive Officer
- 63931
24.1216 USD
10 months ago
Dec 19, 2023
Sell 2.8 K USD
Gunzburg Janet
Principal Accounting Officer
- 118
23.723 USD
11 months ago
Dec 18, 2023
Sell 5.42 K USD
Linetsky David
SVP, Life Sciences
- 234
23.1527 USD
10 months ago
Dec 19, 2023
Sell 593 USD
Linetsky David
SVP, Life Sciences
- 25
23.723 USD
1 year ago
Nov 01, 2023
Sell 3.99 K USD
Gunzburg Janet
Principal Accounting Officer
- 298
13.3831 USD
1 year ago
Oct 16, 2023
Sell 19.9 K USD
Davidoff Michael J.
SVP, Payer Business
- 1198
16.609 USD
1 year ago
Oct 16, 2023
Sell 14.3 K USD
Gandhi Balaji
Chief Financial Officer
- 861
16.609 USD
1 year ago
Oct 16, 2023
Sell 11 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 665
16.609 USD
1 year ago
Oct 16, 2023
Sell 21.5 K USD
Hoffman Allison C
General Counsel & Secretary
- 1297
16.609 USD
1 year ago
Oct 16, 2023
Sell 32.7 K USD
Roberts Evan
Chief Operating Officer
- 1971
16.609 USD
1 year ago
Oct 16, 2023
Sell 34.5 K USD
Linetsky David
SVP, Life Sciences
- 2078
16.609 USD
1 year ago
Oct 16, 2023
Sell 54.7 K USD
Indig Chaim
Chief Executive Officer
- 3295
16.609 USD
1 year ago
Sep 18, 2023
Sell 2.47 K USD
Gunzburg Janet
Principal Accounting Officer
- 125
19.7892 USD
1 year ago
Sep 18, 2023
Sell 1.29 K USD
Linetsky David
SVP, Life Sciences
- 66
19.5912 USD
1 year ago
Sep 18, 2023
Sell 749 USD
Linetsky David
SVP, Life Sciences
- 38
19.71 USD
1 year ago
Sep 18, 2023
Sell 515 USD
Linetsky David
SVP, Life Sciences
- 26
19.7892 USD
1 year ago
Sep 13, 2023
Sell 76.2 K USD
Roberts Evan
Chief Operating Officer
- 3751
20.3031 USD
1 year ago
Sep 13, 2023
Sell 3.31 K USD
Roberts Evan
Chief Operating Officer
- 156
21.2047 USD
1 year ago
Sep 13, 2023
Sell 63.5 K USD
Hoffman Allison C
General Counsel & Secretary
- 3126
20.3031 USD
1 year ago
Sep 13, 2023
Sell 2.76 K USD
Hoffman Allison C
General Counsel & Secretary
- 130
21.2047 USD
1 year ago
Sep 14, 2023
Sell 44.6 K USD
Hoffman Allison C
General Counsel & Secretary
- 2210
20.1656 USD
1 year ago
Sep 13, 2023
Sell 35.6 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 1753
20.3031 USD
1 year ago
Sep 13, 2023
Sell 1.55 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 73
21.2047 USD
1 year ago
Sep 14, 2023
Sell 40.3 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 2000
20.1579 USD
1 year ago
Sep 13, 2023
Sell 18.2 K USD
Gunzburg Janet
Principal Accounting Officer
- 897
20.3031 USD
1 year ago
Sep 13, 2023
Sell 785 USD
Gunzburg Janet
Principal Accounting Officer
- 37
21.2047 USD
1 year ago
Sep 13, 2023
Sell 77.1 K USD
Gandhi Balaji
Chief Financial Officer
- 3799
20.3031 USD
1 year ago
Sep 13, 2023
Sell 3.35 K USD
Gandhi Balaji
Chief Financial Officer
- 158
21.2047 USD
1 year ago
Sep 13, 2023
Sell 70.3 K USD
Davidoff Michael J.
SVP, Payer Business
- 3462
20.3031 USD
1 year ago
Sep 13, 2023
Sell 3.05 K USD
Davidoff Michael J.
SVP, Payer Business
- 144
21.2047 USD
1 year ago
Sep 14, 2023
Sell 59.5 K USD
Davidoff Michael J.
SVP, Payer Business
- 2953
20.1616 USD
1 year ago
Sep 13, 2023
Sell 128 K USD
Indig Chaim
Chief Executive Officer
- 6293
20.3031 USD
1 year ago
Sep 13, 2023
Sell 5.56 K USD
Indig Chaim
Chief Executive Officer
- 262
21.2047 USD
1 year ago
Sep 13, 2023
Sell 40.1 K USD
Linetsky David
SVP, Life Sciences
- 1977
20.3031 USD
1 year ago
Sep 13, 2023
Sell 1.74 K USD
Linetsky David
SVP, Life Sciences
- 82
21.2047 USD
1 year ago
Sep 13, 2023
Sell 2.31 K USD
Linetsky David
SVP, Life Sciences
- 114
20.3031 USD
1 year ago
Sep 13, 2023
Sell 106 USD
Linetsky David
SVP, Life Sciences
- 5
21.2047 USD
1 year ago
Jul 21, 2023
Sell 34.1 K USD
Davidoff Michael J.
SVP, Payer Business
- 1075
31.75 USD
1 year ago
May 10, 2023
Sell 107 K USD
Munson Gillian
Director
- 3555
30.0601 USD
1 year ago
Apr 21, 2023
Sell 35.6 K USD
Davidoff Michael J.
SVP, Payer Business
- 1075
33.13 USD
1 year ago
Apr 18, 2023
Sell 239 K USD
Roberts Evan
Chief Operating Officer
- 7452
32.0943 USD
1 year ago
Apr 17, 2023
Sell 18.1 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 570
31.8401 USD
1 year ago
Apr 17, 2023
Sell 67.2 K USD
Gandhi Balaji
Chief Financial Officer
- 2113
31.8258 USD
1 year ago
Apr 17, 2023
Sell 83.2 K USD
Roberts Evan
Chief Operating Officer
- 2600
32.0111 USD
1 year ago
Apr 14, 2023
Sell 103 K USD
Hoffman Allison C
General Counsel & Secretary
- 3306
31.1607 USD
1 year ago
Apr 12, 2023
Sell 6.4 K USD
Roberts Evan
Chief Operating Officer
- 200
32.01 USD
1 year ago
Apr 11, 2023
Sell 107 K USD
Davidoff Michael J.
SVP, Payer Business
- 3466
30.907 USD
1 year ago
Apr 03, 2023
Sell 82.2 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 2678
30.6903 USD
1 year ago
Apr 03, 2023
Sell 9.51 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 300
31.6933 USD
1 year ago
Apr 03, 2023
Sell 199 K USD
Smith Mark Douglas
Director
- 6500
30.6895 USD
1 year ago
Apr 03, 2023
Sell 15.9 K USD
Smith Mark Douglas
Director
- 500
31.771 USD
1 year ago
Feb 02, 2023
Sell 191 K USD
Rasmussen Randy
Chief Financial Officer
- 4765
40 USD
1 year ago
Feb 02, 2023
Sell 450 K USD
Linetsky David
SVP, Life Sciences
- 11378
39.549 USD
1 year ago
Feb 02, 2023
Sell 12 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 300
40 USD
1 year ago
Feb 02, 2023
Sell 234 K USD
Davidoff Michael J.
SVP, Payer Business
- 5983
39.1189 USD
1 year ago
Feb 02, 2023
Sell 60.5 K USD
Davidoff Michael J.
SVP, Payer Business
- 1530
39.5528 USD
1 year ago
Jan 30, 2023
Sell 441 K USD
Davidoff Michael J.
SVP, Payer Business
- 12293
35.8858 USD
1 year ago
Jan 30, 2023
Sell 590 K USD
Davidoff Michael J.
SVP, Payer Business
- 16262
36.2591 USD
1 year ago
Jan 31, 2023
Sell 124 K USD
Davidoff Michael J.
SVP, Payer Business
- 3265
38.0037 USD
1 year ago
Jan 18, 2023
Sell 23.4 K USD
Hoffman Allison C
director: General Counsel & Secretary
- 649
36.0662 USD
1 year ago
Jan 03, 2023
Sell 265 K USD
Roberts Evan
director: Chief Operating Officer
- 8504
31.1209 USD
1 year ago
Jan 03, 2023
Sell 29.1 K USD
Roberts Evan
director: Chief Operating Officer
- 899
32.3687 USD
1 year ago
Jan 03, 2023
Sell 19.8 K USD
Roberts Evan
director: Chief Operating Officer
- 597
33.1671 USD
1 year ago
Dec 20, 2022
Sell 12.7 K USD
VanDuyn Amy Beth
director: SVP, Human Resources
- 378
33.7292 USD
1 year ago
Dec 13, 2022
Sell 107 K USD
Hoffman Allison C
director: General Counsel & Secretary
- 3109
34.4 USD
1 year ago
Dec 14, 2022
Sell 28.8 K USD
Hoffman Allison C
director: General Counsel & Secretary
- 801
36 USD
1 year ago
Dec 13, 2022
Sell 394 K USD
Linetsky David
director: SVP, Life Sciences
- 11377
34.6097 USD
1 year ago
Dec 09, 2022
Sell 799 K USD
Linetsky David
director: SVP, Life Sciences
- 26837
29.775 USD
1 year ago
Dec 09, 2022
Sell 247 K USD
Rasmussen Randy
director: Chief Financial Officer
- 8183
30.1686 USD
1 year ago
Dec 09, 2022
Sell 55 K USD
Rasmussen Randy
director: Chief Financial Officer
- 1751
31.4003 USD
1 year ago
Dec 12, 2022
Sell 235 K USD
Rasmussen Randy
director: Chief Financial Officer
- 7395
31.7665 USD
2 years ago
Nov 02, 2022
Sell 238 K USD
VanDuyn Amy Beth
director: SVP, Human Resources
- 8986
26.4366 USD
2 years ago
Nov 02, 2022
Sell 270 K USD
VanDuyn Amy Beth
director: SVP, Human Resources
- 9955
27.1435 USD
2 years ago
Nov 02, 2022
Sell 11.2 K USD
VanDuyn Amy Beth
director: SVP, Human Resources
- 400
27.9625 USD
2 years ago
Oct 18, 2022
Sell 27.2 K USD
Davidoff Michael J.
director: SVP, Payer Business
- 1075
25.26 USD
2 years ago
Sep 16, 2022
Sell 35.8 K USD
Davidoff Michael J.
SVP, Payer Business
- 1296
27.6024 USD
2 years ago
Sep 15, 2022
Sell 36.9 K USD
Hoffman Allison C
General Counsel & Secretary
- 1290
28.5782 USD
2 years ago
Jul 21, 2022
Sell 35.1 K USD
Davidoff Michael J.
director: SVP, Payer Business
- 1404
25 USD
2 years ago
Jul 11, 2022
Sell 30.8 K USD
Munson Gillian
director:
- 1221
25.2119 USD
2 years ago
Jun 24, 2022
Sell 127 K USD
Davidoff Michael J.
director: SVP, Payer Business
- 5046
25.1099 USD
2 years ago
May 16, 2022
Sell 33.8 K USD
Munson Gillian
director:
- 2106
16.0566 USD
2 years ago
May 09, 2022
Sell 5.59 K USD
Hoffman Allison C
director: General Counsel & Secretary
- 300
18.6233 USD
2 years ago
Jan 19, 2022
Sell 31.9 K USD
Rasmussen Randy
Chief Financial Officer
- 990
32.2064 USD
2 years ago
Jan 19, 2022
Sell 40.9 K USD
Rasmussen Randy
Chief Financial Officer
- 1238
33.0228 USD
3 years ago
Nov 09, 2021
Sell 532 K USD
Rasmussen Randy
Chief Financial Officer
- 7185
73.9793 USD
3 years ago
Nov 08, 2021
Sell 113 K USD
Linetsky David
SVP, Life Sciences
- 1499
75.1214 USD
3 years ago
Nov 05, 2021
Sell 261 K USD
Linetsky David
SVP, Life Sciences
- 3478
75.1531 USD
3 years ago
Nov 01, 2021
Sell 167 K USD
Linetsky David
SVP, Life Sciences
- 2374
70.419 USD
3 years ago
Nov 01, 2021
Sell 219 K USD
Linetsky David
SVP, Life Sciences
- 3077
71.234 USD
4 years ago
Oct 21, 2020
Sell 379 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 10834
35 USD
3 years ago
Oct 15, 2021
Sell 356 K USD
Linetsky David
SVP, Life Sciences
- 5452
65.3584 USD
3 years ago
Sep 01, 2021
Sell 100 K USD
Linetsky David
SVP, Life Sciences
- 1441
69.6303 USD
3 years ago
Sep 01, 2021
Sell 226 K USD
Linetsky David
SVP, Life Sciences
- 3204
70.6692 USD
3 years ago
Sep 01, 2021
Sell 23.8 K USD
Linetsky David
SVP, Life Sciences
- 333
71.3921 USD
3 years ago
Aug 31, 2021
Sell 34.1 K USD
Linetsky David
SVP, Life Sciences
- 474
71.84 USD
3 years ago
Aug 27, 2021
Sell 277 K USD
Linetsky David
SVP, Life Sciences
- 3932
70.4645 USD
3 years ago
Aug 27, 2021
Sell 383 K USD
Linetsky David
SVP, Life Sciences
- 5336
71.6978 USD
3 years ago
Aug 27, 2021
Sell 867 K USD
Linetsky David
SVP, Life Sciences
- 11987
72.357 USD
3 years ago
Aug 27, 2021
Sell 14.6 K USD
Linetsky David
SVP, Life Sciences
- 200
73.05 USD
3 years ago
Aug 27, 2021
Sell 275 K USD
Indig Chaim
Chief Executive Officer
- 3900
70.4539 USD
3 years ago
Aug 27, 2021
Sell 383 K USD
Indig Chaim
Chief Executive Officer
- 5344
71.6921 USD
3 years ago
Aug 30, 2021
Sell 1.88 M USD
Indig Chaim
Chief Executive Officer
- 26373
71.1166 USD
3 years ago
Aug 27, 2021
Sell 3.05 M USD
Indig Chaim
Chief Executive Officer
- 42142
72.4166 USD
3 years ago
Aug 30, 2021
Sell 2.01 M USD
Indig Chaim
Chief Executive Officer
- 28099
71.5621 USD
3 years ago
Aug 30, 2021
Sell 14.5 K USD
Indig Chaim
Chief Executive Officer
- 200
72.44 USD
3 years ago
Aug 27, 2021
Sell 451 K USD
Indig Chaim
Chief Executive Officer
- 6170
73.124 USD
3 years ago
Aug 25, 2021
Sell 35 K USD
Linetsky David
SVP, Life Sciences
- 500
70.038 USD
3 years ago
Aug 26, 2021
Sell 56.1 K USD
Linetsky David
SVP, Life Sciences
- 800
70.0675 USD
3 years ago
Aug 25, 2021
Sell 42 K USD
Indig Chaim
Chief Executive Officer
- 600
70.03 USD
3 years ago
Aug 26, 2021
Sell 56 K USD
Indig Chaim
Chief Executive Officer
- 800
70.045 USD
3 years ago
Aug 25, 2021
Sell 144 K USD
Hoffman Allison C
General Counsel & Secretary
- 2082
69.05 USD
3 years ago
Aug 05, 2021
Sell 578 K USD
Weintraub Michael
Director
- 8236
70.1253 USD
3 years ago
Aug 05, 2021
Sell 133 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 1936
68.7368 USD
3 years ago
Aug 05, 2021
Sell 162 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 2325
69.8323 USD
3 years ago
Aug 05, 2021
Sell 71.4 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 1012
70.595 USD
3 years ago
Aug 05, 2021
Sell 1.98 M USD
Indig Chaim
Chief Executive Officer
- 28120
70.2705 USD
3 years ago
Aug 06, 2021
Sell 117 K USD
Indig Chaim
Chief Executive Officer
- 1660
70.5326 USD
3 years ago
Jul 30, 2021
Sell 7.14 K USD
Indig Chaim
Chief Executive Officer
- 102
70.001 USD
3 years ago
Jul 29, 2021
Sell 475 K USD
Indig Chaim
Chief Executive Officer
- 6779
70.0294 USD
3 years ago
Jul 29, 2021
Sell 123 K USD
Weintraub Michael
Director
- 1754
70.0234 USD
3 years ago
Jul 30, 2021
Sell 700 USD
Weintraub Michael
Director
- 10
70 USD
3 years ago
Jul 20, 2021
Sell 488 K USD
Weintraub Michael
Director
- 7500
65.0849 USD
3 years ago
Jul 21, 2021
Sell 163 K USD
Weintraub Michael
Director
- 2500
65.1468 USD
3 years ago
Jul 16, 2021
Sell 846 K USD
Weintraub Michael
Director
- 13325
63.5101 USD
3 years ago
Jul 16, 2021
Sell 429 K USD
Weintraub Michael
Director
- 6675
64.2592 USD
3 years ago
Jul 08, 2021
Sell 142 K USD
Munson Gillian
Director
- 2255
62.8975 USD
3 years ago
Jul 08, 2021
Sell 51.2 K USD
Munson Gillian
Director
- 800
64.0125 USD
7. News
Phreesia (PHR) Moves 13.9% Higher: Will This Strength Last? Phreesia (PHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term. zacks.com - 1 week ago
Phreesia Sets Release Date for Fiscal Third Quarter 2025 Results ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it will release its fiscal third quarter 2025 financial results after the close of market trading on Monday, Dec. 9, 2024. businesswire.com - 2 weeks ago
Phreesia Achieves Oracle Validated Integration With Oracle Health EHR Expertise for Delivering Proven, Repeatable Integration ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it has achieved Oracle Validated Integration with Oracle Health EHR Expertise for its integration of the Phreesia platform. businesswire.com - 2 weeks ago
Down -10.25% in 4 Weeks, Here's Why Phreesia (PHR) Looks Ripe for a Turnaround Phreesia (PHR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. zacks.com - 1 month ago
Phreesia Joins the Network Advertising Initiative as a Member, Demonstrating Ongoing Commitment to Industry-Leading Privacy Practices ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has joined the NAI to shape the national conversation around data privacy and promote consumer choice and transparency. businesswire.com - 1 month ago
Phreesia and Ad Council Partnership Yields High Patient Engagement in 3 Mental Health Awareness Campaigns ALL-REMOTE COMPANY/WILMINGTON, Del. & NEW YORK--(BUSINESS WIRE)--Phreesia has collaborated with the Ad Council to bring three public health campaigns about mental health directly to patients and caregivers. businesswire.com - 1 month ago
Phreesia Secures New Contract With CMS as Report Shows Gains in Patient Activation in First Year of Kidney Care Choices (KCC) Model ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is pleased to announce that its contract with the CMS Innovation Center for use of the Patient Activation Measure® has been renewed to 2029. businesswire.com - 1 month ago
Phreesia: Remain Bullish Given The Healthy Growth Outlook I maintain a buy rating for PHR, driven by strong client growth, solid revenue outlook, and increasing transaction sizes in the pipeline. PHR's 2Q25 results show 19% y/y revenue growth and improved profitability, with positive EBITDA and FCF, indicating strong financial health. Despite a slight decline in revenue per AHSC, larger client acquisitions and increased transaction sizes support my 20% growth expectation. seekingalpha.com - 2 months ago
Phreesia, Inc. (PHR) Q2 2025 Earnings Call Transcript Phreesia, Inc. (NYSE:PHR ) Q2 2025 Earnings Conference Call September 4, 2024 5:00 PM ET Company Participants Balaji Gandhi - Chief Financial Officer Chaim Indig - Chief Executive Officer Conference Call Participants Anne Samuel - JPMorgan Ryan Daniels - William Blair Scott Schoenhaus - KeyBanc Jessica Tassan - Piper Sandler Jailendra Singh - Truist Securities Glen Santangelo - Jefferies Stephanie Davis - Barclays Joe Vruwink - Baird John Ransom - Raymond James Richard Close - Canaccord Security Daniel Grosslight - Citi Sean Dodge - RBC Capital Markets Jeff Garro - Stephens Matthew Shea - Needham & Company Jack Wallace - Guggenheim Aaron Kimson - Citizens JMP Operator Good evening, ladies and gentlemen, and welcome to the Phreesia Second Quarter Fiscal 2025 Earnings Conference Call. At this time all participants are in a listen-only mode. seekingalpha.com - 2 months ago
Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended July 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com - 2 months ago
Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates Phreesia (PHR) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.68 per share a year ago. zacks.com - 2 months ago
Phreesia (PHR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures Get a deeper insight into the potential performance of Phreesia (PHR) for the quarter ended July 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. zacks.com - 2 months ago
8. Profile Summary

Phreesia, Inc. PHR

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 1.04 B
Dividend Yield 0.00%
Description Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.
Contact 434 Fayetteville Street, Raleigh, NC, 27601 https://www.phreesia.com
IPO Date July 18, 2019
Employees 1438
Officers Mr. Evan Roberts Co-Founder & Chief Operating Officer Ms. Amy Beth VanDuyn Senior Vice President of Human Resources Mr. Chaim Indig Co-Founder, Chief Executive Officer & Director Mr. Balaji Gandhi Chief Financial Officer Ms. Yvonne Hui Vice President & Principal Accounting Officer Ms. Maureen McKinney Vice President of Corporate Communications Dr. Hilary Hatch Ph.D. Chief Clinical Officer Mr. David Linetsky Senior Vice President of Life Sciences Mr. Jack Callahan Chief Technology Officer Mr. Ashwin G. Uttamchandani Vice President of Sales & Marketing Operations